非血吸虫性膀胱鳞状细胞癌诊疗和预后分析(附21例报告)

谢锡绍; 乔保平; 王雷阳; 冯皓; 李云龙

非血吸虫性膀胱鳞状细胞癌诊疗和预后分析(附21例报告)

- 郑州大学第一附属医院泌尿外科(郑州, 450052)

详细信息

通讯作者: 乔保平,E-mail:zhangyaling@zzu.edu.cn

中图分类号: R737.14

收稿日期: 2012-08-26

Nonbilharzial squamous cell carcinoma of the bladder(Report of 21 cases)

- Department of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China

More Information

Corresponding author: QIAO Baoping, E-mail: zhangyaling@zzu.edu.cn

Received Date: 26 August 2012

摘要

摘要: 目的：探讨非血吸虫性膀胱鳞状细胞癌的病因、诊断、治疗及预后情况。方法：回顾分析21例经术后病理检查证实为膀胱鳞癌患者的临床资料，包括其临床症状、检查、治疗及预后情况，对其预后情况进行相关的统计分析。结果：21患者中主要症状表现为血尿、膀胱刺激症状、泌尿系感染等。患者1年、2年及5年生存率分别为55%、30%和5%，中位生存期16.1个月。初次就诊时T₁期0例，4例发现盆腔淋巴结转移，1例发现肺部转移。接受根治性膀胱全切的患者生存期明显长于未行根治性膀胱全切的患者。随着T分期的增高，患者生存期逐渐减短；盆腔淋巴结转移的4例患者分别于术后8、10、11、18个月死亡，而未发现淋巴结转移的患者中有6例存活至少2年或以上，最长者目前随访75个月仍生存；不同肿瘤分级患者生存期无明显差异。部分患者接受放化疗等辅助治疗，但对患者预后改善不明显。结论：膀胱鳞癌预后差，早期诊断很重要，应尽早行根治性膀胱全切+盆腔淋巴结清扫术以改善患者预后，放化疗在膀胱鳞癌治疗中的作用仍需进一步探讨。
- 膀胱肿瘤 /
- 鳞状细胞癌 /
- 治疗 /
- 预后
Abstract: Objective: To observe the pathogensis,diagnosis,treatment and survival of the Nonbilharzial squamous cell carcinoma of the bladder.Method: The clinical data of 21 cases of nobilharzial squamous cell carcinoma of the bladder from April 2006 to April 2011 of our hospital were reviewed.Result: Among the 21 cases of bladder squamous cell carcinoma,16 patients were male and 5 were female,with a mean age of 62.8 years.Haematuria was the main clinical presentation,and irritative bladder symptoms and urinary tract infection were also seen in these patients.The 1,2 and 5-year survival rates for all patients were 55%,30% and 5% respectively,and the median survival time was 16.1 months.None of 21 patients had a superficial tumor(T₁),4 patients had lymphnode metastases,and there is only one patient had distant metastase.Radical cystectomy could provide higher survival for patients than other therapies.Some patients were submitted to adjuvant chemotherapy and radiotherapy without any significant response.Evidence was provided that tumor stage and lymphnode status are the independent variables which affect survival probability.Conclusion: The prognosis of squamous cell carcinoma of bladder is relatively poor.It is very important for the patients to be early-diagnosed and early-treated.Radical cystectomy remains the mainstay of therapy for squamous cell carcinoma of the bladder.Locoregional recurrence is the primary cause of death in the majority of patients.Extensive surgery is recommended.And the role for neoadjuvant therapy needs further study.
- bladder neoplasm /
- squamous cell carcinoma /
- treatment /
- pronogosis

HTML全文

参考文献(27)

[1]	吴阶平. 泌尿外科[M]. 济南:山东科学技术出版社, 1993:438-475.
[2]	El-Sebaie M, Zaghloul M S, Howard G, et al. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder:a review of etiological features, natural history,and management[J]. Int J Clin Oncol, 2005, 10:20-25.
[3]	管建云, 赵高贤, 张卫星, 等. 冬凌草在膀胱热疗预防膀胱肿瘤复发中的作用[J]. 中原医刊, 2006, 33(12):24-25.
[4]	Horiuchi K, Tsuboi N, Shimizu H, et al. High-frequency endoluminal ultrasonography for staging transitional cell carcinoma of the bladder[J]. Urology, 2000, 56:404-407.
[5]	Stenzl A, Cowan N C, Stantis M D, et al. Guidelines on Bladder Cancer Muscle-invasive and Metastatic[J]. European Association of Urology, 2008.
[6]	Pattison S, Choong S, Corbishley C M, et al. Squamous cell carcinom a of the bladder, interm ittent self-catheterization and urinary tract infection——is there an association[J]? BJU Int, 2001, 88:441.
[7]	Khan M S, Thornhill J A, Gaffney E, et al. Keratinising squamous metaplasia of the bladder:natural history and rationalization of management based on review of 54 years experience[J]. Eur Urol, 2002, 42:469-474.
[8]	Hess M J, Zhan E H, Foo D K, et al. Bladder cancer in patients with spinal cord injury[J]. J Spinal Cord Med, 2003, 26:335-338
[9]	Serretta V, Pomara G, Piazzo F, et al. Pure squamous cell carcinoma of the bladder in western countries[J]. Eur Urol, 2000, 37:85-89.
[10]	Browne R F, Murphy S M, Grainger R, et al. CT cystography and virtual cystcopy in the assessment of new and recurrent bladder neoplasms[J]. Eur J Radiol, 2005, 53:147-153.
[11]	Lammle M, Beer A, Settles M, et al. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder[J]. AJR Am J Roettgenol, 2002, 178:1438-1488.
[12]	Shaaban A A, Tribukait B, el-Bedeiwy A F, et al. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis:a report of 100 cases[J]. J Urol, 1990, 144:879-883.
[13]	Navon J D, Soliman H, Khonsari F, et al. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder[J]. J Urol, 1997, 157:2109-2111.
[14]	Celis J E, Rasmussen H H, Vorum H, et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine[J]. J Urol, 1996, 155:2105-2112.
[15]	Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder:is survival different with stage adjustment[J]? Urology, 2009, 73:822-827.
[16]	Rundle J S, Hart A J, McGeorge A, et al. Squamous cell carcinoma of bladder. A review of 114 patients[J]. Br J Urol, 1982, 54:522-526.
[17]	Serretta V, Pomara G, Piazza F, et al. Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases[J]. Eur Urol, 2000, 37:85-89.
[18]	Swanson D A, Liles A, Zagars G K. Pre-operative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder[J]. J Urol, 1990, 143:37-40.
[19]	Kassouf W, Spiess P E, Siefker-Radtke A, et al. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder:A contemporary review of The University of Texas MD Anderson Cancer Center experience[J]. Cancer, 2007, 110:764-769.
[20]	Ghoneim M A, Krane R J, Siroky M B, et al. Non Transitional cell bladder cancer[M]. In eds. Clinical Urology. Chap 7. Philadelphia:Lippincott Co, 1994:679-687.
[21]	EI-Sebaie M, Zaghloul M S, Howard G, et al. Squamous cell carcinoma of the bilharzial and non-bilharzial unriary bladder:A review of etiological features, natural histry, and management[J]. Int J Clin Oncol, 2005, 10:20-25.
[22]	Rausch S, Hofmann R, von Knobloch R. Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tract[J]. Urol Ann, 2012, 4:14-18.
[23]	Inui M, Fujita K, Ueda N, et al. A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy[J]. Hinyokika Kiyo, 2002, 48:33-35.
[24]	Haysahi N, Asano K, Furuta A, et al. Invasive squamous cell carcinoma of the bladder:Report of 18 cases and review of literature[J]. Nippon Hinyokika Gakkai Zasshi, 2004, 95:711-717.
[25]	Ghoneim M A, Abdel-Latif M, el-Mekresh M, et al. Radical cystectomy for carcinoma of the bladder:2,720 consecutive cases 5 years later[J]. J Urol, 2008, 180:121-127.
[26]	Abol-Enein H, El-Baz M, Abd El-Hameed M A, et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy:a patho-anatomical study——a single center experience[J]. J Urol, 2004, 172:1818-1821.
[27]	Mills R D, Turner W H, Fleischmann A, et al. Pelvic lymph node metastases from bladder cancer:outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy[J]. J Urol, 2001, 166:19-23.